These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 32134646)

  • 41. De novo design with deep generative models based on 3D similarity scoring.
    Papadopoulos K; Giblin KA; Janet JP; Patronov A; Engkvist O
    Bioorg Med Chem; 2021 Aug; 44():116308. PubMed ID: 34280849
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure-Based
    Ma B; Terayama K; Matsumoto S; Isaka Y; Sasakura Y; Iwata H; Araki M; Okuno Y
    J Chem Inf Model; 2021 Jul; 61(7):3304-3313. PubMed ID: 34242036
    [TBL] [Abstract][Full Text] [Related]  

  • 43. GRELinker: A Graph-Based Generative Model for Molecular Linker Design with Reinforcement and Curriculum Learning.
    Zhang H; Huang J; Xie J; Huang W; Yang Y; Xu M; Lei J; Chen H
    J Chem Inf Model; 2024 Feb; 64(3):666-676. PubMed ID: 38241022
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Artificial Intelligence in Compound Design.
    Grebner C; Matter H; Hessler G
    Methods Mol Biol; 2022; 2390():349-382. PubMed ID: 34731477
    [TBL] [Abstract][Full Text] [Related]  

  • 45. De Novo Design of Bioactive Small Molecules by Artificial Intelligence.
    Merk D; Friedrich L; Grisoni F; Schneider G
    Mol Inform; 2018 Jan; 37(1-2):. PubMed ID: 29319225
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exploring the QSAR's predictive truthfulness of the novel N-tuple discrete derivative indices on benchmark datasets.
    Martínez-Santiago O; Marrero-Ponce Y; Vivas-Reyes R; Rivera-Borroto OM; Hurtado E; Treto-Suarez MA; Ramos Y; Vergara-Murillo F; Orozco-Ugarriza ME; Martínez-López Y
    SAR QSAR Environ Res; 2017 May; 28(5):367-389. PubMed ID: 28590848
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MoleGuLAR: Molecule Generation Using Reinforcement Learning with Alternating Rewards.
    Goel M; Raghunathan S; Laghuvarapu S; Priyakumar UD
    J Chem Inf Model; 2021 Dec; 61(12):5815-5826. PubMed ID: 34866384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RECAP--retrosynthetic combinatorial analysis procedure: a powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry.
    Lewell XQ; Judd DB; Watson SP; Hann MM
    J Chem Inf Comput Sci; 1998; 38(3):511-22. PubMed ID: 9611787
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Shape-Based Generative Modeling for de Novo Drug Design.
    Skalic M; Jiménez J; Sabbadin D; De Fabritiis G
    J Chem Inf Model; 2019 Mar; 59(3):1205-1214. PubMed ID: 30762364
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Augmented Hill-Climb increases reinforcement learning efficiency for language-based de novo molecule generation.
    Thomas M; O'Boyle NM; Bender A; de Graaf C
    J Cheminform; 2022 Oct; 14(1):68. PubMed ID: 36192789
    [TBL] [Abstract][Full Text] [Related]  

  • 51. QSAR modeling of anti-invasive activity of organic compounds using structural descriptors.
    Katritzky AR; Kuanar M; Dobchev DA; Vanhoecke BW; Karelson M; Parmar VS; Stevens CV; Bracke ME
    Bioorg Med Chem; 2006 Oct; 14(20):6933-9. PubMed ID: 16908166
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Optimizing blood-brain barrier permeation through deep reinforcement learning for de novo drug design.
    Pereira T; Abbasi M; Oliveira JL; Ribeiro B; Arrais J
    Bioinformatics; 2021 Jul; 37(Suppl_1):i84-i92. PubMed ID: 34252946
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Generating and screening de novo compounds against given targets using ultrafast deep learning models as core components.
    Zhang H; Saravanan KM; Yang Y; Wei Y; Yi P; Zhang JZH
    Brief Bioinform; 2022 Jul; 23(4):. PubMed ID: 35724626
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Generative Models for De Novo Drug Design.
    Tong X; Liu X; Tan X; Li X; Jiang J; Xiong Z; Xu T; Jiang H; Qiao N; Zheng M
    J Med Chem; 2021 Oct; 64(19):14011-14027. PubMed ID: 34533311
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deep inverse reinforcement learning for structural evolution of small molecules.
    Agyemang B; Wu WP; Addo D; Kpiebaareh MY; Nanor E; Roland Haruna C
    Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33348357
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimization of binding affinities in chemical space with generative pre-trained transformer and deep reinforcement learning.
    Xu X; Zhou J; Zhu C; Zhan Q; Li Z; Zhang R; Wang Y; Liao X; Gao X
    F1000Res; 2023; 12():757. PubMed ID: 38434657
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is chemical synthetic accessibility computationally predictable for drug and lead-like molecules? A comparative assessment between medicinal and computational chemists.
    Bonnet P
    Eur J Med Chem; 2012 Aug; 54():679-89. PubMed ID: 22749644
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Computational Method for Structure-Based Analysis of SAR Transfer.
    Bonanni D; Lolli ML; Bajorath J
    J Med Chem; 2020 Feb; 63(3):1388-1396. PubMed ID: 31939664
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adaptive configuring of radial basis function network by hybrid particle swarm algorithm for QSAR studies of organic compounds.
    Zhou YP; Jiang JH; Lin WQ; Zou HY; Wu HL; Shen GL; Yu RQ
    J Chem Inf Model; 2006; 46(6):2494-501. PubMed ID: 17125190
    [TBL] [Abstract][Full Text] [Related]  

  • 60. GuacaMol: Benchmarking Models for de Novo Molecular Design.
    Brown N; Fiscato M; Segler MHS; Vaucher AC
    J Chem Inf Model; 2019 Mar; 59(3):1096-1108. PubMed ID: 30887799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.